Mitchell S. Anscher

MedicinePhysics and Astronomy

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Costs and Complications After a Diagnosis of Prostate Cancer Treated With Time-Efficient Modalities: An Analysis of National Medicare Data”.

Costs and Complications After a Diagnosis of Prostate Cancer Treated With Time-Efficient Modalities: An Analysis of National Medicare Data

Practical Radiation Oncology(2020)10.1016/j.prro.2020.02.014

N/A

0.425DataRank · unranked

16 citations

Xiudong Lei, Grace L. Smith, Hubert Y. Pan, Kenneth R. Hess, Aileen B. Chen +8 more

Moderately Hypofractionated Intensity Modulated Radiation Therapy With Simultaneous Integrated Boost for Prostate Cancer: Five-Year Toxicity Results From a Prospective Phase I/II Trial

Frontiers in Oncology(2020)10.3389/fonc.2020.01686

N/A

0.334DataRank · unranked

5 citations

Nitai D. Mukhopadhyay, Xiaoyan Deng, Diane Holdford, Vicki Skinner, Siddharth Saraiya +4 more

Quality comparison between three-dimensional T2-weighted SPACE and two-dimensional T2-weighted turbo spin echo magnetic resonance images for the brachytherapy planning evaluation of prostate and periprostatic anatomy

Brachytherapy(2020)10.1016/j.brachy.2020.04.001

N/A

0DataRank · unranked

14 citations

Aradhana M. Venkatesan, Jingfei Ma, Priyadarshini Bhosale, Wei Wei, Rajat J. Kudchadker +7 more

Moderately Hypofractionated Intensity Modulated Radiation Therapy with Simultaneous Integrated Boost for Prostate Cancer: Five-Year Toxicity Results from a Prospective Phase I/II Trial

(2020)10.21203/rs.3.rs-28814/v1

N/A

0DataRank · unranked

1 citations

Nitai D. Mukhopadhyay, Xiaoyan Deng, Diane Holdford, Vicki Skinner, Siddharth Saraiya +4 more

Five-year results from a phase I/II study of moderately hypofractionated intensity-modulated radiation therapy (IMRT) for localized prostate cancer including simultaneously integrated boost and pelvic lymph node (LN) coverage.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.299

N/A

0DataRank · unranked

0 citations

Nitai D. Mukhopadhyay, Diane Holdford, Vicki Skinner, Siddharth Saraiya, Drew Moghanaki +4 more